Human Phenotype Ontology 
Grandparent Node:
expand
Abnormal eye physiology (HP:0012373)help
Parent Node:
expand
Abnormal visual electrophysiology (HP:0030453)help
..Starting node
..expand
Abnormality of visual evoked potentials (HP:0000649)help
Term ID: 649
Name: Abnormality of visual evoked potentials
Synonym: Abnormal vision evoked potentials; Abnormal visual evoked potential; Abnormal visual evoked responses; Abnormal visual-evoked potentials; VEP abnormalities
Definition: An anomaly of visually evoked potentials (VEP), which are electrical potentials, initiated by brief visual stimuli, which are recorded from the scalp overlying the visual cortex.
Comments:
Reference: HP:0000649
Genes and Diseases:
 
       Child Nodes:
........expandAbnormal flash visual evoked potentials (HP:0007928) help
................... HP:0030461 Abnormal timing of flash visual evoked potentials
................... HP:0030462 Abnormal amplitude of flash visual evoked potentials
................... HP:0030463 Asymmetrical distribution of flash visual evoked potentials
........expandUndetectable visual evoked potentials (HP:0007965) help
........expandAbnormality of pattern visual evoked potentials (HP:0030455) help
................... HP:0030456 Abnormality of pattern onset/offset visual evoked potentials
................... HP:0100289 Abnormality of pattern reversal visual evoked potentials

 Sister Nodes: 
..expandAbnormal electrooculogram (HP:0030454) help
..expandAbnormal electroretinogram (HP:0000512) help
InputHPO IDHPO termDistanceGeneGene id entrezDiseaseIdDiseaseNameDiseaseMIMConceptIDSourceTypical associationHGMD variantsClinVar variantsHGNC IDGeneMIM
 
HPO disease - gene - phenotype typical associations:
HP:0000649HP:0000649Abnormality of visual evoked potentials0AAAS CL E G H8086231550Glucocorticoid deficiency with achalasia231550C0271742OMIM17911713666605378
HP:0000649HP:0000649Abnormality of visual evoked potentials0ABCA4 CL E G H24827Stargardt diseaseC0271093ORPHA11280211234601691
HP:0000649HP:0000649Abnormality of visual evoked potentials0ACOX1 CL E G H512971ORPHA126384119609751
HP:0000649HP:0000649Abnormality of visual evoked potentials0ARHGEF2 CL E G H9181617523Neurodevelopmental disorder with midbrain and hindbrain malformations617523C4479613OMIM1237682607560
HP:0000649HP:0000649Abnormality of visual evoked potentials0ASPA CL E G H443314911ORPHA1102244756608034
HP:0000649HP:0000649Abnormality of visual evoked potentials0CLCN7 CL E G H1186667ORPHA11003852025602727
HP:0000649HP:0000649Abnormality of visual evoked potentials0CNGB3 CL E G H54714827Stargardt diseaseC0271093ORPHA11265892153605080
HP:0000649HP:0000649Abnormality of visual evoked potentials0ELOVL4 CL E G H6785827Stargardt diseaseC0271093ORPHA11717514415605512
HP:0000649HP:0000649Abnormality of visual evoked potentials0ERCC6 CL E G H2074133540Cockayne syndrome B133540C0751038OMIM11408153438609413
HP:0000649HP:0000649Abnormality of visual evoked potentials0ERCC8 CL E G H1161216400Cockayne syndrome type A216400C0751039OMIM1703093439609412
HP:0000649HP:0000649Abnormality of visual evoked potentials0FXN CL E G H2395229300Friedreich ataxia 1229300C1856689OMIM1661303951606829
HP:0000649HP:0000649Abnormality of visual evoked potentials0GJC2 CL E G H57165320401ORPHA15716717494608803
HP:0000649HP:0000649Abnormality of visual evoked potentials0MFN2 CL E G H9927601152Hereditary motor and sensory neuropathy with optic atrophy601152C0393807OMIM123180916877608507
HP:0000649HP:0000649Abnormality of visual evoked potentials0NDRG1 CL E G H10397601455Charcot-Marie-Tooth disease, type 4D601455C1832334OMIM194977679605262
HP:0000649HP:0000649Abnormality of visual evoked potentials0NOTCH3 CL E G H4854125310Cerebral autosomal dominant arteriopathy with subcortical infarcts and leukoencephalopathy125310C0751587OMIM13798367883600276
HP:0000649HP:0000649Abnormality of visual evoked potentials0PLA2G6 CL E G H8398256600Infantile neuroaxonal dystrophy256600C0270724OMIM11794139039603604
HP:0000649HP:0000649Abnormality of visual evoked potentials0POGZ CL E G H23126616364White-sutton syndrome616364C4225351OMIM15434618801614787
HP:0000649HP:0000649Abnormality of visual evoked potentials0POLG CL E G H5428203700Progressive sclerosing poliodystrophy203700C0205710OMIM130014389179174763
HP:0000649HP:0000649Abnormality of visual evoked potentials0PROM1 CL E G H8842827Stargardt diseaseC0271093ORPHA1835039454604365
HP:0000649HP:0000649Abnormality of visual evoked potentials0PRPH2 CL E G H5961827Stargardt diseaseC0271093ORPHA11815259942179605
HP:0000649HP:0000649Abnormality of visual evoked potentials0RAB18 CL E G H229312510ORPHA1516914244602207
HP:0000649HP:0000649Abnormality of visual evoked potentials0RAB3GAP1 CL E G H229302510ORPHA16726517063602536
HP:0000649HP:0000649Abnormality of visual evoked potentials0RAB3GAP2 CL E G H257822510ORPHA11639217168609275
HP:0000649HP:0000649Abnormality of visual evoked potentials0SLC25A22 CL E G H79751609304Early myoclonic encephalopathy609304C0270855OMIM11038019954609302
HP:0000649HP:0000649Abnormality of visual evoked potentials0SNX10 CL E G H29887667ORPHA1135614974614780
HP:0000649HP:0000649Abnormality of visual evoked potentials0SUCLA2 CL E G H88031933ORPHA12923711448603921
HP:0000649HP:0000649Abnormality of visual evoked potentials0TBC1D20 CL E G H1286372510ORPHA1713516133611663
HP:0000649HP:0000649Abnormality of visual evoked potentials0TCIRG1 CL E G H10312667ORPHA113754311647604592
HP:0000649HP:0000649Abnormality of visual evoked potentials0TNFSF11 CL E G H8600667ORPHA11612811926602642
HP:0000649HP:0000649Abnormality of visual evoked potentials0TYR CL E G H729979431ORPHA144525212442606933
HP:0000649HP:0000649Abnormality of visual evoked potentials1AAAS CL E G H8086231550Glucocorticoid deficiency with achalasia231550C0271742OMIM17911713666605378
HP:0000649HP:0000649Abnormality of visual evoked potentials1ABCA4 CL E G H24827Stargardt diseaseC0271093ORPHA11280211234601691
HP:0000649HP:0000649Abnormality of visual evoked potentials1ACOX1 CL E G H512971ORPHA126384119609751
HP:0000649HP:0000649Abnormality of visual evoked potentials1ARHGEF2 CL E G H9181617523Neurodevelopmental disorder with midbrain and hindbrain malformations617523C4479613OMIM1237682607560
HP:0000649HP:0000649Abnormality of visual evoked potentials1ASPA CL E G H443314911ORPHA1102244756608034
HP:0000649HP:0000649Abnormality of visual evoked potentials1CLCN7 CL E G H1186667ORPHA11003852025602727
HP:0000649HP:0000649Abnormality of visual evoked potentials1CNGB3 CL E G H54714827Stargardt diseaseC0271093ORPHA11265892153605080
HP:0000649HP:0000649Abnormality of visual evoked potentials1ELOVL4 CL E G H6785827Stargardt diseaseC0271093ORPHA11717514415605512
HP:0000649HP:0000649Abnormality of visual evoked potentials1ERCC6 CL E G H2074133540Cockayne syndrome B133540C0751038OMIM11408153438609413
HP:0000649HP:0000649Abnormality of visual evoked potentials1ERCC8 CL E G H1161216400Cockayne syndrome type A216400C0751039OMIM1703093439609412
HP:0000649HP:0000649Abnormality of visual evoked potentials1FXN CL E G H2395229300Friedreich ataxia 1229300C1856689OMIM1661303951606829
HP:0000649HP:0000649Abnormality of visual evoked potentials1GJC2 CL E G H57165320401ORPHA15716717494608803
HP:0000649HP:0000649Abnormality of visual evoked potentials1MFN2 CL E G H9927601152Hereditary motor and sensory neuropathy with optic atrophy601152C0393807OMIM123180916877608507
HP:0000649HP:0000649Abnormality of visual evoked potentials1NDRG1 CL E G H10397601455Charcot-Marie-Tooth disease, type 4D601455C1832334OMIM194977679605262
HP:0000649HP:0000649Abnormality of visual evoked potentials1NOTCH3 CL E G H4854125310Cerebral autosomal dominant arteriopathy with subcortical infarcts and leukoencephalopathy125310C0751587OMIM13798367883600276
HP:0000649HP:0000649Abnormality of visual evoked potentials1PLA2G6 CL E G H8398256600Infantile neuroaxonal dystrophy256600C0270724OMIM11794139039603604
HP:0000649HP:0000649Abnormality of visual evoked potentials1POGZ CL E G H23126616364White-sutton syndrome616364C4225351OMIM15434618801614787
HP:0000649HP:0000649Abnormality of visual evoked potentials1POLG CL E G H5428203700Progressive sclerosing poliodystrophy203700C0205710OMIM130014389179174763
HP:0000649HP:0000649Abnormality of visual evoked potentials1PROM1 CL E G H8842827Stargardt diseaseC0271093ORPHA1835039454604365
HP:0000649HP:0000649Abnormality of visual evoked potentials1PRPH2 CL E G H5961827Stargardt diseaseC0271093ORPHA11815259942179605
HP:0000649HP:0000649Abnormality of visual evoked potentials1RAB18 CL E G H229312510ORPHA1516914244602207
HP:0000649HP:0000649Abnormality of visual evoked potentials1RAB3GAP1 CL E G H229302510ORPHA16726517063602536
HP:0000649HP:0000649Abnormality of visual evoked potentials1RAB3GAP2 CL E G H257822510ORPHA11639217168609275
HP:0000649HP:0000649Abnormality of visual evoked potentials1SLC25A22 CL E G H79751609304Early myoclonic encephalopathy609304C0270855OMIM11038019954609302
HP:0000649HP:0000649Abnormality of visual evoked potentials1SNX10 CL E G H29887667ORPHA1135614974614780
HP:0000649HP:0000649Abnormality of visual evoked potentials1SUCLA2 CL E G H88031933ORPHA12923711448603921
HP:0000649HP:0000649Abnormality of visual evoked potentials1TBC1D20 CL E G H1286372510ORPHA1713516133611663
HP:0000649HP:0000649Abnormality of visual evoked potentials1TCIRG1 CL E G H10312667ORPHA113754311647604592
HP:0000649HP:0000649Abnormality of visual evoked potentials1TNFSF11 CL E G H8600667ORPHA11612811926602642
HP:0000649HP:0000649Abnormality of visual evoked potentials1TYR CL E G H729979431ORPHA144525212442606933
HP:0000649HP:0000649Abnormality of visual evoked potentials2AAAS CL E G H8086231550Glucocorticoid deficiency with achalasia231550C0271742OMIM17911713666605378
HP:0000649HP:0000649Abnormality of visual evoked potentials2ABCA4 CL E G H24827Stargardt diseaseC0271093ORPHA11280211234601691
HP:0000649HP:0000649Abnormality of visual evoked potentials2ACOX1 CL E G H512971ORPHA126384119609751
HP:0000649HP:0000649Abnormality of visual evoked potentials2ARHGEF2 CL E G H9181617523Neurodevelopmental disorder with midbrain and hindbrain malformations617523C4479613OMIM1237682607560
HP:0000649HP:0000649Abnormality of visual evoked potentials2ASPA CL E G H443314911ORPHA1102244756608034
HP:0000649HP:0000649Abnormality of visual evoked potentials2CLCN7 CL E G H1186667ORPHA11003852025602727
HP:0000649HP:0000649Abnormality of visual evoked potentials2CNGB3 CL E G H54714827Stargardt diseaseC0271093ORPHA11265892153605080
HP:0000649HP:0000649Abnormality of visual evoked potentials2ELOVL4 CL E G H6785827Stargardt diseaseC0271093ORPHA11717514415605512
HP:0000649HP:0000649Abnormality of visual evoked potentials2ERCC6 CL E G H2074133540Cockayne syndrome B133540C0751038OMIM11408153438609413
HP:0000649HP:0000649Abnormality of visual evoked potentials2ERCC8 CL E G H1161216400Cockayne syndrome type A216400C0751039OMIM1703093439609412
HP:0000649HP:0000649Abnormality of visual evoked potentials2FXN CL E G H2395229300Friedreich ataxia 1229300C1856689OMIM1661303951606829
HP:0000649HP:0000649Abnormality of visual evoked potentials2GJC2 CL E G H57165320401ORPHA15716717494608803
HP:0000649HP:0000649Abnormality of visual evoked potentials2MFN2 CL E G H9927601152Hereditary motor and sensory neuropathy with optic atrophy601152C0393807OMIM123180916877608507
HP:0000649HP:0000649Abnormality of visual evoked potentials2NDRG1 CL E G H10397601455Charcot-Marie-Tooth disease, type 4D601455C1832334OMIM194977679605262
HP:0000649HP:0000649Abnormality of visual evoked potentials2NOTCH3 CL E G H4854125310Cerebral autosomal dominant arteriopathy with subcortical infarcts and leukoencephalopathy125310C0751587OMIM13798367883600276
HP:0000649HP:0000649Abnormality of visual evoked potentials2PLA2G6 CL E G H8398256600Infantile neuroaxonal dystrophy256600C0270724OMIM11794139039603604
HP:0000649HP:0000649Abnormality of visual evoked potentials2POGZ CL E G H23126616364White-sutton syndrome616364C4225351OMIM15434618801614787
HP:0000649HP:0000649Abnormality of visual evoked potentials2POLG CL E G H5428203700Progressive sclerosing poliodystrophy203700C0205710OMIM130014389179174763
HP:0000649HP:0000649Abnormality of visual evoked potentials2PROM1 CL E G H8842827Stargardt diseaseC0271093ORPHA1835039454604365
HP:0000649HP:0000649Abnormality of visual evoked potentials2PRPH2 CL E G H5961827Stargardt diseaseC0271093ORPHA11815259942179605
HP:0000649HP:0000649Abnormality of visual evoked potentials2RAB18 CL E G H229312510ORPHA1516914244602207
HP:0000649HP:0000649Abnormality of visual evoked potentials2RAB3GAP1 CL E G H229302510ORPHA16726517063602536
HP:0000649HP:0000649Abnormality of visual evoked potentials2RAB3GAP2 CL E G H257822510ORPHA11639217168609275
HP:0000649HP:0000649Abnormality of visual evoked potentials2SLC25A22 CL E G H79751609304Early myoclonic encephalopathy609304C0270855OMIM11038019954609302
HP:0000649HP:0000649Abnormality of visual evoked potentials2SNX10 CL E G H29887667ORPHA1135614974614780
HP:0000649HP:0000649Abnormality of visual evoked potentials2SUCLA2 CL E G H88031933ORPHA12923711448603921
HP:0000649HP:0000649Abnormality of visual evoked potentials2TBC1D20 CL E G H1286372510ORPHA1713516133611663
HP:0000649HP:0000649Abnormality of visual evoked potentials2TCIRG1 CL E G H10312667ORPHA113754311647604592
HP:0000649HP:0000649Abnormality of visual evoked potentials2TNFSF11 CL E G H8600667ORPHA11612811926602642
HP:0000649HP:0000649Abnormality of visual evoked potentials2TYR CL E G H729979431ORPHA144525212442606933
HP:0000649HP:0000649Abnormality of visual evoked potentials3AAAS CL E G H8086231550Glucocorticoid deficiency with achalasia231550C0271742OMIM17911713666605378
HP:0000649HP:0000649Abnormality of visual evoked potentials3ABCA4 CL E G H24827Stargardt diseaseC0271093ORPHA11280211234601691
HP:0000649HP:0000649Abnormality of visual evoked potentials3ACOX1 CL E G H512971ORPHA126384119609751
HP:0000649HP:0000649Abnormality of visual evoked potentials3ARHGEF2 CL E G H9181617523Neurodevelopmental disorder with midbrain and hindbrain malformations617523C4479613OMIM1237682607560
HP:0000649HP:0000649Abnormality of visual evoked potentials3ASPA CL E G H443314911ORPHA1102244756608034
HP:0000649HP:0000649Abnormality of visual evoked potentials3CLCN7 CL E G H1186667ORPHA11003852025602727
HP:0000649HP:0000649Abnormality of visual evoked potentials3CNGB3 CL E G H54714827Stargardt diseaseC0271093ORPHA11265892153605080
HP:0000649HP:0000649Abnormality of visual evoked potentials3ELOVL4 CL E G H6785827Stargardt diseaseC0271093ORPHA11717514415605512
HP:0000649HP:0000649Abnormality of visual evoked potentials3ERCC6 CL E G H2074133540Cockayne syndrome B133540C0751038OMIM11408153438609413
HP:0000649HP:0000649Abnormality of visual evoked potentials3ERCC8 CL E G H1161216400Cockayne syndrome type A216400C0751039OMIM1703093439609412
HP:0000649HP:0000649Abnormality of visual evoked potentials3FXN CL E G H2395229300Friedreich ataxia 1229300C1856689OMIM1661303951606829
HP:0000649HP:0000649Abnormality of visual evoked potentials3GJC2 CL E G H57165320401ORPHA15716717494608803
HP:0000649HP:0000649Abnormality of visual evoked potentials3MFN2 CL E G H9927601152Hereditary motor and sensory neuropathy with optic atrophy601152C0393807OMIM123180916877608507
HP:0000649HP:0000649Abnormality of visual evoked potentials3NDRG1 CL E G H10397601455Charcot-Marie-Tooth disease, type 4D601455C1832334OMIM194977679605262
HP:0000649HP:0000649Abnormality of visual evoked potentials3NOTCH3 CL E G H4854125310Cerebral autosomal dominant arteriopathy with subcortical infarcts and leukoencephalopathy125310C0751587OMIM13798367883600276
HP:0000649HP:0000649Abnormality of visual evoked potentials3PLA2G6 CL E G H8398256600Infantile neuroaxonal dystrophy256600C0270724OMIM11794139039603604
HP:0000649HP:0000649Abnormality of visual evoked potentials3POGZ CL E G H23126616364White-sutton syndrome616364C4225351OMIM15434618801614787
HP:0000649HP:0000649Abnormality of visual evoked potentials3POLG CL E G H5428203700Progressive sclerosing poliodystrophy203700C0205710OMIM130014389179174763
HP:0000649HP:0000649Abnormality of visual evoked potentials3PROM1 CL E G H8842827Stargardt diseaseC0271093ORPHA1835039454604365
HP:0000649HP:0000649Abnormality of visual evoked potentials3PRPH2 CL E G H5961827Stargardt diseaseC0271093ORPHA11815259942179605
HP:0000649HP:0000649Abnormality of visual evoked potentials3RAB18 CL E G H229312510ORPHA1516914244602207
HP:0000649HP:0000649Abnormality of visual evoked potentials3RAB3GAP1 CL E G H229302510ORPHA16726517063602536
HP:0000649HP:0000649Abnormality of visual evoked potentials3RAB3GAP2 CL E G H257822510ORPHA11639217168609275
HP:0000649HP:0000649Abnormality of visual evoked potentials3SLC25A22 CL E G H79751609304Early myoclonic encephalopathy609304C0270855OMIM11038019954609302
HP:0000649HP:0000649Abnormality of visual evoked potentials3SNX10 CL E G H29887667ORPHA1135614974614780
HP:0000649HP:0000649Abnormality of visual evoked potentials3SUCLA2 CL E G H88031933ORPHA12923711448603921
HP:0000649HP:0000649Abnormality of visual evoked potentials3TBC1D20 CL E G H1286372510ORPHA1713516133611663
HP:0000649HP:0000649Abnormality of visual evoked potentials3TCIRG1 CL E G H10312667ORPHA113754311647604592
HP:0000649HP:0000649Abnormality of visual evoked potentials3TNFSF11 CL E G H8600667ORPHA11612811926602642
HP:0000649HP:0000649Abnormality of visual evoked potentials3TYR CL E G H729979431ORPHA144525212442606933
 
HPO disease - gene - phenotype less frequent non-typical associations:
HP:0000649HP:0000649Abnormality of visual evoked potentials0ARSA CL E G H410309256ORPHA0254723713607574
HP:0000649HP:0000649Abnormality of visual evoked potentials0ARSA CL E G H410309263ORPHA0254723713607574
HP:0000649HP:0000649Abnormality of visual evoked potentials0ARSA CL E G H410309271ORPHA0254723713607574
HP:0000649HP:0000649Abnormality of visual evoked potentials0ELOVL4 CL E G H6785614457Ichthyosis, spastic quadriplegia, and mental retardation614457C3280856OMIM01717514415605512
HP:0000649HP:0000649Abnormality of visual evoked potentials0EMC1 CL E G H23065616875Cerebellar atrophy, visual impairment, and psychomotor retardation616875C4225172OMIM0728428957616846
HP:0000649HP:0000649Abnormality of visual evoked potentials0LAMA2 CL E G H3908258Schmitt Gillenwater Kelly syndromeORPHA038022816482156225
HP:0000649HP:0000649Abnormality of visual evoked potentials0MT-CO1 CL E G H4512550ORPHA07419516030
HP:0000649HP:0000649Abnormality of visual evoked potentials0MT-CO2 CL E G H4513550ORPHA07421516040
HP:0000649HP:0000649Abnormality of visual evoked potentials0MT-CO3 CL E G H4514550ORPHA07422516050
HP:0000649HP:0000649Abnormality of visual evoked potentials0MT-ND1 CL E G H4535550ORPHA07455516000
HP:0000649HP:0000649Abnormality of visual evoked potentials0MT-ND4 CL E G H4538550ORPHA07459516003
HP:0000649HP:0000649Abnormality of visual evoked potentials0MT-ND5 CL E G H4540550ORPHA07461516005
HP:0000649HP:0000649Abnormality of visual evoked potentials0MT-ND6 CL E G H4541550ORPHA07462516006
HP:0000649HP:0000649Abnormality of visual evoked potentials0MT-TF CL E G H4558550ORPHA07481590070
HP:0000649HP:0000649Abnormality of visual evoked potentials0MT-TH CL E G H4564550ORPHA07487590040
HP:0000649HP:0000649Abnormality of visual evoked potentials0MT-TL1 CL E G H4567550ORPHA07490590050
HP:0000649HP:0000649Abnormality of visual evoked potentials0MT-TQ CL E G H4572550ORPHA07495590030
HP:0000649HP:0000649Abnormality of visual evoked potentials0MT-TS1 CL E G H4574550ORPHA07497590080
HP:0000649HP:0000649Abnormality of visual evoked potentials0MT-TS2 CL E G H4575550ORPHA07498590085
HP:0000649HP:0000649Abnormality of visual evoked potentials0MT-TW CL E G H4578550ORPHA07501590095
HP:0000649HP:0000649Abnormality of visual evoked potentials0OPA1 CL E G H49761215Cerebro reno digital syndromeORPHA03945638140605290
HP:0000649HP:0000649Abnormality of visual evoked potentials0PSAP CL E G H5660309256ORPHA0273889498176801
HP:0000649HP:0000649Abnormality of visual evoked potentials0PSAP CL E G H5660309263ORPHA0273889498176801
HP:0000649HP:0000649Abnormality of visual evoked potentials0PSAP CL E G H5660309271ORPHA0273889498176801
HP:0000649HP:0000649Abnormality of visual evoked potentials0TTPA CL E G H727496ORPHA03021612404600415
HP:0000649HP:0000649Abnormality of visual evoked potentials1ARSA CL E G H410309263ORPHA0254723713607574
HP:0000649HP:0000649Abnormality of visual evoked potentials1ARSA CL E G H410309271ORPHA0254723713607574
HP:0000649HP:0000649Abnormality of visual evoked potentials1ARSA CL E G H410309256ORPHA0254723713607574
HP:0000649HP:0000649Abnormality of visual evoked potentials1ELOVL4 CL E G H6785614457Ichthyosis, spastic quadriplegia, and mental retardation614457C3280856OMIM01717514415605512
HP:0000649HP:0000649Abnormality of visual evoked potentials1EMC1 CL E G H23065616875Cerebellar atrophy, visual impairment, and psychomotor retardation616875C4225172OMIM0728428957616846
HP:0000649HP:0000649Abnormality of visual evoked potentials1LAMA2 CL E G H3908258Schmitt Gillenwater Kelly syndromeORPHA038022816482156225
HP:0000649HP:0000649Abnormality of visual evoked potentials1MT-CO1 CL E G H4512550ORPHA07419516030
HP:0000649HP:0000649Abnormality of visual evoked potentials1MT-CO2 CL E G H4513550ORPHA07421516040
HP:0000649HP:0000649Abnormality of visual evoked potentials1MT-CO3 CL E G H4514550ORPHA07422516050
HP:0000649HP:0000649Abnormality of visual evoked potentials1MT-ND1 CL E G H4535550ORPHA07455516000
HP:0000649HP:0000649Abnormality of visual evoked potentials1MT-ND4 CL E G H4538550ORPHA07459516003
HP:0000649HP:0000649Abnormality of visual evoked potentials1MT-ND5 CL E G H4540550ORPHA07461516005
HP:0000649HP:0000649Abnormality of visual evoked potentials1MT-ND6 CL E G H4541550ORPHA07462516006
HP:0000649HP:0000649Abnormality of visual evoked potentials1MT-TF CL E G H4558550ORPHA07481590070
HP:0000649HP:0000649Abnormality of visual evoked potentials1MT-TH CL E G H4564550ORPHA07487590040
HP:0000649HP:0000649Abnormality of visual evoked potentials1MT-TL1 CL E G H4567550ORPHA07490590050
HP:0000649HP:0000649Abnormality of visual evoked potentials1MT-TQ CL E G H4572550ORPHA07495590030
HP:0000649HP:0000649Abnormality of visual evoked potentials1MT-TS1 CL E G H4574550ORPHA07497590080
HP:0000649HP:0000649Abnormality of visual evoked potentials1MT-TS2 CL E G H4575550ORPHA07498590085
HP:0000649HP:0000649Abnormality of visual evoked potentials1MT-TW CL E G H4578550ORPHA07501590095
HP:0000649HP:0000649Abnormality of visual evoked potentials1OPA1 CL E G H49761215Cerebro reno digital syndromeORPHA03945638140605290
HP:0000649HP:0000649Abnormality of visual evoked potentials1PSAP CL E G H5660309263ORPHA0273889498176801
HP:0000649HP:0000649Abnormality of visual evoked potentials1PSAP CL E G H5660309271ORPHA0273889498176801
HP:0000649HP:0000649Abnormality of visual evoked potentials1PSAP CL E G H5660309256ORPHA0273889498176801
HP:0000649HP:0000649Abnormality of visual evoked potentials1TTPA CL E G H727496ORPHA03021612404600415
HP:0000649HP:0000649Abnormality of visual evoked potentials2ARSA CL E G H410309271ORPHA0254723713607574
HP:0000649HP:0000649Abnormality of visual evoked potentials2ARSA CL E G H410309256ORPHA0254723713607574
HP:0000649HP:0000649Abnormality of visual evoked potentials2ARSA CL E G H410309263ORPHA0254723713607574
HP:0000649HP:0000649Abnormality of visual evoked potentials2ELOVL4 CL E G H6785614457Ichthyosis, spastic quadriplegia, and mental retardation614457C3280856OMIM01717514415605512
HP:0000649HP:0000649Abnormality of visual evoked potentials2EMC1 CL E G H23065616875Cerebellar atrophy, visual impairment, and psychomotor retardation616875C4225172OMIM0728428957616846
HP:0000649HP:0000649Abnormality of visual evoked potentials2LAMA2 CL E G H3908258Schmitt Gillenwater Kelly syndromeORPHA038022816482156225
HP:0000649HP:0000649Abnormality of visual evoked potentials2MT-CO1 CL E G H4512550ORPHA07419516030
HP:0000649HP:0000649Abnormality of visual evoked potentials2MT-CO2 CL E G H4513550ORPHA07421516040
HP:0000649HP:0000649Abnormality of visual evoked potentials2MT-CO3 CL E G H4514550ORPHA07422516050
HP:0000649HP:0000649Abnormality of visual evoked potentials2MT-ND1 CL E G H4535550ORPHA07455516000
HP:0000649HP:0000649Abnormality of visual evoked potentials2MT-ND4 CL E G H4538550ORPHA07459516003
HP:0000649HP:0000649Abnormality of visual evoked potentials2MT-ND5 CL E G H4540550ORPHA07461516005
HP:0000649HP:0000649Abnormality of visual evoked potentials2MT-ND6 CL E G H4541550ORPHA07462516006
HP:0000649HP:0000649Abnormality of visual evoked potentials2MT-TF CL E G H4558550ORPHA07481590070
HP:0000649HP:0000649Abnormality of visual evoked potentials2MT-TH CL E G H4564550ORPHA07487590040
HP:0000649HP:0000649Abnormality of visual evoked potentials2MT-TL1 CL E G H4567550ORPHA07490590050
HP:0000649HP:0000649Abnormality of visual evoked potentials2MT-TQ CL E G H4572550ORPHA07495590030
HP:0000649HP:0000649Abnormality of visual evoked potentials2MT-TS1 CL E G H4574550ORPHA07497590080
HP:0000649HP:0000649Abnormality of visual evoked potentials2MT-TS2 CL E G H4575550ORPHA07498590085
HP:0000649HP:0000649Abnormality of visual evoked potentials2MT-TW CL E G H4578550ORPHA07501590095
HP:0000649HP:0000649Abnormality of visual evoked potentials2OPA1 CL E G H49761215Cerebro reno digital syndromeORPHA03945638140605290
HP:0000649HP:0000649Abnormality of visual evoked potentials2PSAP CL E G H5660309271ORPHA0273889498176801
HP:0000649HP:0000649Abnormality of visual evoked potentials2PSAP CL E G H5660309256ORPHA0273889498176801
HP:0000649HP:0000649Abnormality of visual evoked potentials2PSAP CL E G H5660309263ORPHA0273889498176801
HP:0000649HP:0000649Abnormality of visual evoked potentials2TTPA CL E G H727496ORPHA03021612404600415
HP:0000649HP:0000649Abnormality of visual evoked potentials3ARSA CL E G H410309256ORPHA0254723713607574
HP:0000649HP:0000649Abnormality of visual evoked potentials3ARSA CL E G H410309263ORPHA0254723713607574
HP:0000649HP:0000649Abnormality of visual evoked potentials3ARSA CL E G H410309271ORPHA0254723713607574
HP:0000649HP:0000649Abnormality of visual evoked potentials3ELOVL4 CL E G H6785614457Ichthyosis, spastic quadriplegia, and mental retardation614457C3280856OMIM01717514415605512
HP:0000649HP:0000649Abnormality of visual evoked potentials3EMC1 CL E G H23065616875Cerebellar atrophy, visual impairment, and psychomotor retardation616875C4225172OMIM0728428957616846
HP:0000649HP:0000649Abnormality of visual evoked potentials3LAMA2 CL E G H3908258Schmitt Gillenwater Kelly syndromeORPHA038022816482156225
HP:0000649HP:0000649Abnormality of visual evoked potentials3MT-CO1 CL E G H4512550ORPHA07419516030
HP:0000649HP:0000649Abnormality of visual evoked potentials3MT-CO2 CL E G H4513550ORPHA07421516040
HP:0000649HP:0000649Abnormality of visual evoked potentials3MT-CO3 CL E G H4514550ORPHA07422516050
HP:0000649HP:0000649Abnormality of visual evoked potentials3MT-ND1 CL E G H4535550ORPHA07455516000
HP:0000649HP:0000649Abnormality of visual evoked potentials3MT-ND4 CL E G H4538550ORPHA07459516003
HP:0000649HP:0000649Abnormality of visual evoked potentials3MT-ND5 CL E G H4540550ORPHA07461516005
HP:0000649HP:0000649Abnormality of visual evoked potentials3MT-ND6 CL E G H4541550ORPHA07462516006
HP:0000649HP:0000649Abnormality of visual evoked potentials3MT-TF CL E G H4558550ORPHA07481590070
HP:0000649HP:0000649Abnormality of visual evoked potentials3MT-TH CL E G H4564550ORPHA07487590040
HP:0000649HP:0000649Abnormality of visual evoked potentials3MT-TL1 CL E G H4567550ORPHA07490590050
HP:0000649HP:0000649Abnormality of visual evoked potentials3MT-TQ CL E G H4572550ORPHA07495590030
HP:0000649HP:0000649Abnormality of visual evoked potentials3MT-TS1 CL E G H4574550ORPHA07497590080
HP:0000649HP:0000649Abnormality of visual evoked potentials3MT-TS2 CL E G H4575550ORPHA07498590085
HP:0000649HP:0000649Abnormality of visual evoked potentials3MT-TW CL E G H4578550ORPHA07501590095
HP:0000649HP:0000649Abnormality of visual evoked potentials3OPA1 CL E G H49761215Cerebro reno digital syndromeORPHA03945638140605290
HP:0000649HP:0000649Abnormality of visual evoked potentials3PSAP CL E G H5660309256ORPHA0273889498176801
HP:0000649HP:0000649Abnormality of visual evoked potentials3PSAP CL E G H5660309263ORPHA0273889498176801
HP:0000649HP:0000649Abnormality of visual evoked potentials3PSAP CL E G H5660309271ORPHA0273889498176801
HP:0000649HP:0000649Abnormality of visual evoked potentials3TTPA CL E G H727496ORPHA03021612404600415


Genes (55) :AAAS ABCA4 ACOX1 ARHGEF2 ARSA ASPA ATXN1 CLCN7 CNGB3 COX1 COX2 COX3 ELOVL4 EMC1 ERCC6 ERCC8 FXN GALC GJC2 LAMA2 MFN2 ND1 ND4 ND5 ND6 NDRG1 NOTCH3 OPA1 PLA2G6 POGZ POLG POMGNT1 PROM1 PRPH2 PSAP RAB18 RAB3GAP1 RAB3GAP2 SCAPER SLC25A22 SNX10 SUCLA2 TBC1D20 TCIRG1 TNFSF11 TRNF TRNH TRNL1 TRNQ TRNS1 TRNS2 TRNW TTPA TYR ZNHIT3

Diseases (37) :231550 827 2971 617523 309271 309256 309263 314911 667 550 614457 616875 133540 216400 229300 320401 258 601152 601455 125310 1215 256600 616364 203700 2510 609304 1933 96 79431 98755 245200 614225 618195 260565 125250 165500 253280
 

Human Phenotype Ontology(HPO) is developed by the Human Phenotype Ontology Consortium. The version used here is June 2019 release.